Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. Keeping that in mind, here are two profitable companies that balance growth and profitability and one that may face some trouble.
One Stock to Sell:
Janus (JBI)
Trailing 12-Month GAAP Operating Margin: 12.6%
Standing out with its digital keyless entry into self-storage room technology, Janus (NYSE:JBI) is a provider of easily accessible self-storage solutions.
Why Does JBI Worry Us?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 8.9% annually over the last two years
- Falling earnings per share over the last two years has some investors worried as stock prices ultimately follow EPS over the long term
- Diminishing returns on capital suggest its earlier profit pools are drying up
At $5.48 per share, Janus trades at 8.6x forward P/E. Check out our free in-depth research report to learn more about why JBI doesn’t pass our bar.
Two Stocks to Watch:
Sea (SE)
Trailing 12-Month GAAP Operating Margin: 8.5%
Founded in 2009 and a publicly traded company since 2017, Sea (NYSE:SE) started as a gaming platform and has since expanded to offer a variety of services such as e-commerce, digital payments, and financial services across Southeast Asia.
Why Will SE Outperform?
- Paying Users are rising, meaning the company can increase revenue without incurring additional customer acquisition costs if it can cross-sell additional products and features
- Additional sales over the last three years increased its profitability as the 60.9% annual growth in its earnings per share outpaced its revenue
- Free cash flow margin increased by 30.7 percentage points over the last few years, giving the company more capital to invest or return to shareholders
Sea is trading at $86.38 per share, or 13x forward EV/EBITDA. Is now the right time to buy? See for yourself in our full research report, it’s free.
Stryker (SYK)
Trailing 12-Month GAAP Operating Margin: 19.5%
With over 150 million patients impacted annually through its innovative healthcare technologies, Stryker (NYSE:SYK) develops and manufactures advanced medical devices and equipment across orthopedics, surgical tools, neurotechnology, and patient care solutions.
Why Does SYK Stand Out?
- Average organic revenue growth of 10.2% over the past two years demonstrates its ability to expand independently without relying on acquisitions
- Economies of scale give it some operating leverage when demand rises
- Incremental sales over the last five years have been more profitable as its earnings per share increased by 12.9% annually, topping its revenue gains
Stryker’s stock price of $330.50 implies a valuation ratio of 21.8x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.